Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic System--Cancer”

1,833 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,833 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07193420
What this trial is testing

Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
GVHD - Graft-Versus-Host DiseaseHSCTHaploidentical Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 180
Post-approval studies (Phase 4)UnknownNCT02576327
What this trial is testing

A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Vomiting
Jun Zhu 130
Post-approval studies (Phase 4)UnknownNCT04738955
What this trial is testing

Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors

Who this might be right for
Hematological Tumors Patients With High Risk Factors of Invasive Fungal Disease
Shandong Provincial Hospital 230
Testing effectiveness (Phase 2)WithdrawnNCT00728585
What this trial is testing

Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant

Who this might be right for
Gastrointestinal MucositisMalignant Neoplasm
Children's Oncology Group
Testing effectiveness (Phase 2)Study completedNCT02500550
What this trial is testing

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Kiadis Pharma 15
Testing effectiveness (Phase 2)Looking for participantsNCT06909110
What this trial is testing

Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity

Who this might be right for
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus Infections
Jessie L. Alexander 25
Not applicableUnknownNCT06041815
What this trial is testing

Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies

Who this might be right for
Hematological MalignanciesChimeric Antigen Receptor T-cell Therapy
The First Affiliated Hospital of Soochow University 100
Not applicableNot Yet RecruitingNCT07612085
What this trial is testing

A Wearable Biosensor Patch for Non-Invasive Monitoring for Patients Undergoing Abdominal or Chest Surgery

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT00104858
What this trial is testing

Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaProlymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+6 more
Fred Hutchinson Cancer Center 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT04262843
What this trial is testing

Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaHigh Risk Myelodysplastic Syndrome+1 more
City of Hope Medical Center 33
Not applicableStudy completedNCT00574886
What this trial is testing

Idiotype Vaccine After Chemotherapy & Stem Cell Transplantation in Lymphoma With Failed Induction Chemotherapy

Who this might be right for
Lymphoma
University of Nebraska 2
Not applicableLooking for participantsNCT06150469
What this trial is testing

Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological Malignancies

Who this might be right for
Hematological Malignancies
University Hospital, Limoges 286
Not applicableNot Yet RecruitingNCT07235501
What this trial is testing

Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Versus Host DiseaseHematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
City of Hope Medical Center 75
Not applicableLooking for participantsNCT03207854
What this trial is testing

Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers

Who this might be right for
Healthy SubjectHematologic and Lymphocytic DisorderHematopoietic and Lymphoid Cell Neoplasm+2 more
University of Southern California 625
Testing effectiveness (Phase 2)Study completedNCT01288573
What this trial is testing

A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone

Who this might be right for
Ewing's Sarcoma/Soft Tissue SarcomaNeuroblastomaBrain Tumors
Genzyme, a Sanofi Company 46
Testing effectiveness (Phase 2)Looking for participantsNCT07109323
What this trial is testing

Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM

Who this might be right for
Ultra High Risk mm (uhr-mm), 18-70 Years Old, Suitable for ASCT. And Meet Any of the Following uhr-mm DefinitionsCytogenetics Ultra High RiskPrimary Refractory+4 more
Institute of Hematology & Blood Diseases Hospital, China 50
Testing effectiveness (Phase 2)Study completedNCT02988466
What this trial is testing

Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

Who this might be right for
Hematologic Malignancies
Masonic Cancer Center, University of Minnesota 78
Post-approval studies (Phase 4)UnknownNCT05545202
What this trial is testing

A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation

Who this might be right for
Malignant LymphomaMultiple Myeloma
Pharmacosmos A/S 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT01628029
What this trial is testing

Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSleep Disorder
M.D. Anderson Cancer Center 68
Testing effectiveness (Phase 2)Study completedNCT03159702
What this trial is testing

Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation

Who this might be right for
Hematological MalignancyMultiple Myeloma
Medical College of Wisconsin 43
Load More Results